Animikh Ray

688 total citations
10 papers, 511 citations indexed

About

Animikh Ray is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Animikh Ray has authored 10 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Pharmaceutical Science and 2 papers in Immunology. Recurrent topics in Animikh Ray's work include Advanced Drug Delivery Systems (3 papers), RNA Interference and Gene Delivery (2 papers) and Heavy Metal Exposure and Toxicity (1 paper). Animikh Ray is often cited by papers focused on Advanced Drug Delivery Systems (3 papers), RNA Interference and Gene Delivery (2 papers) and Heavy Metal Exposure and Toxicity (1 paper). Animikh Ray collaborates with scholars based in United States, India and Algeria. Animikh Ray's co-authors include Bidhan Chandra Koner, Basu Dev Banerjee, Abhirup Mandal, Mary Joseph, Ranjana Mitra, Ashim K. Mitra, Hoang M. Trinh, Dhananjay Pal, Vibhuti Agrahari and Vivek Agrahari and has published in prestigious journals such as PLoS ONE, Molecular Neurobiology and Heliyon.

In The Last Decade

Animikh Ray

10 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Animikh Ray United States 5 153 145 126 102 98 10 511
Adina Amir Israel 15 178 1.2× 18 0.1× 106 0.8× 258 2.5× 153 1.6× 33 733
Dinesh G. Goswami United States 14 55 0.4× 32 0.2× 28 0.2× 92 0.9× 162 1.7× 36 471
Hongmin Zhang China 11 86 0.6× 14 0.1× 126 1.0× 53 0.5× 60 0.6× 25 362
Jamin A. Willoughby Poland 14 73 0.5× 18 0.1× 16 0.1× 13 0.1× 137 1.4× 25 603
Vicente Nogués Switzerland 5 27 0.2× 36 0.2× 12 0.1× 45 0.4× 133 1.4× 7 469
E.V. Buehler United States 13 152 1.0× 40 0.3× 13 0.1× 25 0.2× 58 0.6× 26 750
S. Kalweit Germany 11 43 0.3× 34 0.2× 16 0.1× 15 0.1× 117 1.2× 14 573
Seyyed Masoud Davoudi Iran 15 42 0.3× 34 0.2× 10 0.1× 24 0.2× 116 1.2× 31 668
Diane Berson United States 20 23 0.2× 109 0.8× 14 0.1× 15 0.1× 80 0.8× 37 1.4k
Stefan Proniuk United States 13 49 0.3× 85 0.6× 35 0.3× 12 0.1× 101 1.0× 23 392

Countries citing papers authored by Animikh Ray

Since Specialization
Citations

This map shows the geographic impact of Animikh Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Animikh Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Animikh Ray more than expected).

Fields of papers citing papers by Animikh Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Animikh Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Animikh Ray. The network helps show where Animikh Ray may publish in the future.

Co-authorship network of co-authors of Animikh Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Animikh Ray. A scholar is included among the top collaborators of Animikh Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Animikh Ray. Animikh Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Ray, Animikh, et al.. (2022). Sodium fluoride induces skeletal muscle atrophy via changes in mitochondrial and sarcomeric proteomes. PLoS ONE. 17(12). e0279261–e0279261. 3 indexed citations
3.
Kulkarni, Venkatrao H., et al.. (2021). Ellagic acid restored lead-induced nephrotoxicity by anti-inflammatory, anti-apoptotic and free radical scavenging activities. Heliyon. 7(1). e05921–e05921. 38 indexed citations
4.
Ray, Animikh, Abhirup Mandal, Mary Joseph, & Ashim K. Mitra. (2016). Recent Patents on Nanoparticles and Nanoformulations for Cancer Therapy. Recent Patents on Drug Delivery & Formulation. 10(1). 11–23. 6 indexed citations
5.
Agrahari, Vibhuti, Abhirup Mandal, Vivek Agrahari, et al.. (2016). A comprehensive insight on ocular pharmacokinetics. Drug Delivery and Translational Research. 6(6). 735–754. 325 indexed citations
6.
Ray, Animikh, et al.. (2016). Doxorubicin prodrug for cytoplasmic and nuclear delivery in breast cancer cells. 7(1). 13–13. 3 indexed citations
7.
Ray, Animikh, Abhirup Mandal, & Ashim K. Mitra. (2015). Recent Patents in Pulmonary Delivery of Macromolecules. Recent Patents on Drug Delivery & Formulation. 9(3). 230–241. 13 indexed citations
8.
Yang, Xiaoyan, Sheng Ye, Animikh Ray, et al.. (2015). Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells. Drug Delivery. 23(7). 2532–2540. 2 indexed citations
9.
Parida, Pravat Kumar, et al.. (2011). Chitosan micro and nanoparticles for delivery of drugs and therapeutic proteins. 4 indexed citations
10.
Koner, Bidhan Chandra, Basu Dev Banerjee, & Animikh Ray. (1998). Organochlorine pesticide-induced oxidative stress and immune suppression in rats.. PubMed. 36(4). 395–8. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026